CCBs: calcium channel blockers; ERAs: endothelin receptor antagonists; O2: oxygen; PA: pulmonary artery; PDE-5is: phosphodiesterase type 5 inhibitors; WHO-FC: World Health Organization functional class.
aClass of recommendation.
bLevel of evidence.
cReference(s) supporting recommendations.